United Kingdom Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self-Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump Analysis - (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies) Companies Analysis 2023-2028
United Kingdom Diabetes Market
United Kingdom Diabetes Market will reach US$ 7.77 Billion in 2028 according to Renub Research. The United Kingdom has the worst diabetes condition in Europe, with the most overweight and obese adults, according to the WHO. As a result, United Kingdom, have more people than ever with diabetes. Diabetes is a chronic disease that happens either when the pancreas does not make sufficient insulin or when the body cannot beneficially use the insulin it produces.
United Kingdom Diabetes Industry to expand at a CAGR of 5.96% from 2022 to 2028
One of the biggest health challenges that the United Kingdom is facing nowadays is diabetes. Increasing health problems and complications will raise awareness of the risks, enhance self-management among people with diabetes, bring about wholesale lifestyle changes, and improve access to integrated diabetes care services. According to our research report, United Kingdom Diabetes Market was US$ 5.49 Billion in 2022.
1 in 14 people in the UK has diabetes, and the number of people diagnosed has doubled in the last 15 years.
The United Kingdom Diabetes Market is driven by the rise in unit sales and lessened by ASP depreciation. The critical driver of growth will be the upsurge in the diabetic population in the country and the increasing number of patients that require various diabetes care devices to manage their disease daily. There has been a rise in the diagnosis number of people living with diabetes in the U.K. According to the British Diabetes Association Data, diabetes patients increased by over 1.5 thousand in 2020, and the number will rise to 5.5 Million if the current trends continue and warned of a "public health emergency" by 2030.
More and more People will have Type 2 Diabetes in United Kingdom
The rate of newly diagnosed cases of Type 1 and Type 2 diabetes is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic care products. According to The British Diabetic Association, Diabetes prevalence 2021 data shows a rise in the number of with a diabetes in the UK. It is estimated that more than 13.6 Million are at increased risk of type 2 diabetes in the UK. At this rate, the number of diabetes people, including the undiagnosed diabetes population, is expected to rise to 5.5 Million by 2030.
Insulin Pen dominates the Market due to the High Number of Diabetes Patients
The U.K. diabetes market is classified into Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring (CGM) Devices, Insulin pens, and Insulin Pumps. The frequency of occurrence of diabetes patients and the introduction of new and improved technology in the healthcare sector are key elements fuelling growth in the U.K. market for insulin pen production and sales. The other driving forces are the increasing awareness related to needle stick injuries, diabetes monitoring and therapeutics for better disease management, and the rise in the adoption of attached medical devices.
The market share for insulin pumps will rise during the forecast period. The factors contributing to this growth are the surging cases of diabetes and awareness regarding the use of insulin pumps in the country. In addition, these pumps also provide distinct clinical benefits paired with new advanced features, like integrated CGM sensors, smartphone connectivity, etc., which fuel the demand for insulin pumps.
Government Initiatives will aid the Market
The National Service Framework (NSF) program improves services by setting national standards to improve the quality of service and tackle variations carefully. In addition, the Association of British HealthTech Industries (ABHI) 2019 launched a diabetes section, allowing diabetes technology companies to work together in one of its forums. The ABHI group is for any health technology company interested in diabetes care, from CGM and insulin pumps to apps.
Key Players:
The major players competing in the United Kingdom Market are B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickenson (B.D.), Novo Nordisk A/S, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Corp., Dexcom Inc., Roche Diagnostic, and Tandem Diabetes Care.
- In April 2022, Abbott, CamDiab, and Ypsomed announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system. The initial focus of the partnership will be on European countries. The connected, smart wearable solution is designed to monitor a person's glucose levels continuously and automatically adjust and deliver the right amount of insulin at the right time, removing the guesswork of insulin dosing.
- In November 2021, ARKRAY, creator of the world's first HLPC HbA1c clinical analyzer, launched its brand in the U.K. and Europe. Its innovative diabetes testing systems are being marketed and supported directly to customers rather than through a distributor.
Renub Research report titled “United Kingdom Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self-Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump Analysis - (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies) Companies (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, InsuletCorporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of United Kingdom Diabetes Industry.
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)
2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump
United Kingdom Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM) – United Kingdom Diabetes Market breakup from four viewpoints
1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
2. SMBG – United Kingdom Diabetes Market breakup from five viewpoints
1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market – United Kingdom Diabetes Market breakup from six viewpoints
1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies
4. Insulin Pump Market – United Kingdom Diabetes Market breakup from four viewpoints
1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies
All the 13 Companies Studied in the Report have been Studied from 3 Points
• Company Overview
• Recent Developments
• Financial Insight
Company Analysis
1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nardisk
6. Ypsomed AG
7. Medtronic
8. InsuletCororation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care
Report Details:
| Report Features | Details |
| Base Year | 2022 |
| Historical Period | 2017 - 2022 |
| Forecast Period | 2023 - 2028 |
| Market | US$ Billion |
| Segment Covered | CGM, SMBG, Insulin Pen, and Insulin Pump |
| Companies Covered | B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, InsuletCorporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
Frequently Asked Questions (FAQ)
- This report provides current market estimates and forecasts for United Kingdom Diabetic Market.
- Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
- Detailed analysis of United Kingdom SMBG Market.
- Detailed analysis of United Kingdom CGM Market.
- Detailed analysis of United Kingdom Insulin Pump Market.
- Detailed analysis of United Kingdom Insulin Pen Market.
- United Kingdom Diabetic Market – Growth Drivers and Challenges.
- Key sustainability strategies adopted by market players.
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. United Kingdom Diabetes Market
6. United Kingdom Diabetes Population
6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
7. Market Share Analysis – United Kingdom Diabetic
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) – Market & Users
8.1 CGM Market by Components
8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market
8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in United Kingdom
9. Blood Glucose Device (SMBG) – United Kingdom Market & Users
9.1 Market
9.1.1 Type 1 Diabetes Market
9.1.2 Type 2 Diabetes Market
9.2 Test Strips Market
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market and Forecast
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement Policies of Blood Glucose Devices in United Kingdom
10. Insulin Pen – United Kingdom Market & User
10.1 Insulin Pen Market
10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market
10.2 Insulin Pen User
10.2.1 Disposable Insulin Pen User
10.2.2 Reusable Insulin Pen User
10.2.3 Smart Insulin Pen User
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies of Insulin Pen in United Kingdom
11. Insulin Pump - United Kingdom Market & Users
11.1 Insulin Pump Market
11.1.1 Type 1 Insulin Pump Market
11.1.2 Type 2 Insulin Pump Market
11.2 Insulin Pump User
11.2.1 Type 1 Insulin Pump User
11.2.2 Type 2 Insulin Pump User
11.3 Differentiation Points of Insulin Pump Products in United Kingdom
11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo
11.4 Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
11.4.1 Medtronic
11.5 Insulet Corporation
11.5.1 Training Structure for New Patients - Insulet Corporation
11.6 Animas Corporation
11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)
11.7 Tandem Diabetes Care
11.8 Reimbursement Policies Insulin Pump
12. Insulin Pen – Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Recent Development
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Recent Development
12.2.3 Revenue
12.3 Terumo Corporation
12.3.1 Overview
12.3.2 Recent Development
12.3.3 Revenue
12.4 BD
12.4.1 Overview
12.4.2 Recent Development
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Recent Development
12.5.3 Revenue
12.6 Ypsomed AG
12.6.1 Overview
12.6.2 Recent Development
12.6.3 Revenue
13. Insulin Pump – Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue
13.2 Insulet Corporation
13.2.1 Overview
13.2.2 Insulin Pump – Product Details
13.2.3 Revenue
14. SMBG – Company Analysis
14.1 DarioHealth Corp
14.1.1 Overview
14.1.2 Recent Development
14.1.3 Revenue
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Recent Development
14.2.3 Revenue
15. CGM – Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue
15.2 Roche
15.2.1 Overview
15.2.2 Recent Development
15.2.3 Revenue
15.3 Tandem Diabetes Care
15.3.1 Overview
15.3.2 Recent Development
15.3.3 Revenue
List of Figures:
Figure-01: United Kingdom – Diabetes Market (Billion US$), 2017 – 2022
Figure-02: United Kingdom – Forecast for Diabetes Market (Billion US$), 2023 – 2028
Figure-03: United Kingdom – Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure-04: United Kingdom – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
Figure-05: United Kingdom – Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure-06: United Kingdom – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
Figure-07: United Kingdom – Glucose Sensor Market (Million US$), 2017 – 2023
Figure-08: United Kingdom – Forecast for Glucose Sensor Market (Million US$), 2023 – 2028
Figure-09: United Kingdom – CGM Transmitter Market (Million US$), 2017 – 2023
Figure-10: United Kingdom – Forecast for CGM Transmitter Market (Million US$), 2023 – 2028
Figure-11: United Kingdom – CGM User (Thousand), 2017 – 2023
Figure-12: United Kingdom – Forecast for CGM User (Thousand),2023 – 2028
Figure-13: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-14: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-15: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-16: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-17: United Kingdom – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-18: United Kingdom – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-19: United Kingdom – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-20: United Kingdom – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-21: United Kingdom – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-22: United Kingdom – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-23: United Kingdom – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-24: United Kingdom – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-25: United Kingdom – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-26: United Kingdom – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-27: United Kingdom – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-28: United Kingdom – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-29: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
Figure-30: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
Figure-31: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
Figure-32: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
Figure-33: United Kingdom – Disposable Insulin Pen Market (Million US$), 2017 – 2023
Figure-34: United Kingdom – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
Figure-35: United Kingdom – Reusable Insulin Pen Market (Million US$), 2017 – 2023
Figure-36: United Kingdom – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
Figure-37: United Kingdom – Smart Insulin Pen Market (Million US$), 2017 – 2023
Figure-38: United Kingdom – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
Figure-39: United Kingdom – Disposable Insulin Pen User (Thousand), 2017 – 2022
Figure-40: United Kingdom – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
Figure-41: United Kingdom – Reusable Insulin Pen User (Thousand), 2017 – 2022
Figure-42: United Kingdom – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
Figure-43: United Kingdom – Smart Insulin Pen User (Thousand), 2017 – 2022
Figure-44: United Kingdom – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
Figure-45: United Kingdom – Insulin Pen Needle Market (Million US$), 2017 – 2023
Figure-46: United Kingdom – Forecast for Pen Needle Market for Market (Million US$), 2023 – 2028
Figure-47: United Kingdom – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-48: United Kingdom – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-49: United Kingdom – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-50: United Kingdom – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-51: United Kingdom – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
Figure-52: United Kingdom – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
Figure-53: United Kingdom – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
Figure-54: United Kingdom – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
Figure-55: B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
Figure-56: B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-57: Eli Lilly – Global Revenue (Billion US$), 2017 – 2022
Figure-58: Eli Lilly – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-59: Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
Figure-60: Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-61: BD – Global Revenue (Billion US$), 2017 – 2022
Figure-62: BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-63: Novo Nordisk A/S – Global Revenue (Billion US$), 2017 – 2022
Figure-64: Novo Nordisk A/S – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-65: Ypsomed AG – Global Revenue (Billion US$), 2017 – 2022
Figure-66: Ypsomed AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-67: Medtronic – Global Revenue (Billion US$), 2017 – 2022
Figure-68: Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-69: Insulet Corporation – Global Revenue (Billion US$), 2017 – 2022
Figure-70: Insulet Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-71: DarioHealth Corp – Global Revenue (Billion US$), 2017 – 2022
Figure-72: DarioHealth Corp – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-73: Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
Figure-74: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-75: Dexcom Inc – Global Revenue (Billion US$), 2017 – 2022
Figure-76: Dexcom Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-77: Roche – Global Revenue (Billion US$), 2017 – 2022
Figure-78: Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-79: Tandem Diabetes Care – Global Revenue (Billion US$), 2017 – 2022
Figure-80: Tandem Diabetes Care – Forecast for Global Revenue (Billion US$), 2023 – 2028
List of Tables:
Table-01: United Kingdom – Diabetes Market Share by Type (Percent), 2017 – 2022
Table-02: United Kingdom – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com